Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses.

Sharma S, Sundararajan A, Suryawanshi A, Kumar N, Veiga-Parga T, Kuchroo VK, Thomas PG, Sangster MY, Rouse BT.

Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):19001-6. doi: 10.1073/pnas.1107087108. Epub 2011 Nov 3.

2.

Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response.

Sehrawat S, Reddy PB, Rajasagi N, Suryawanshi A, Hirashima M, Rouse BT.

PLoS Pathog. 2010 May 6;6(5):e1000882. doi: 10.1371/journal.ppat.1000882.

3.

Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency.

Reddy PB, Sehrawat S, Suryawanshi A, Rajasagi NK, Mulik S, Hirashima M, Rouse BT.

J Immunol. 2011 Dec 1;187(11):5745-55. doi: 10.4049/jimmunol.1102105. Epub 2011 Oct 21.

4.

Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia.

Zhou Q, Munger ME, Veenstra RG, Weigel BJ, Hirashima M, Munn DH, Murphy WJ, Azuma M, Anderson AC, Kuchroo VK, Blazar BR.

Blood. 2011 Apr 28;117(17):4501-10. doi: 10.1182/blood-2010-10-310425. Epub 2011 Mar 8.

5.

Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.

Nagahara K, Arikawa T, Oomizu S, Kontani K, Nobumoto A, Tateno H, Watanabe K, Niki T, Katoh S, Miyake M, Nagahata S, Hirabayashi J, Kuchroo VK, Yamauchi A, Hirashima M.

J Immunol. 2008 Dec 1;181(11):7660-9.

6.

Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8+ T Cell Function and Impaired Viral Clearance.

Lupfer CR, Stokes KL, Kuriakose T, Kanneganti TD.

J Virol. 2017 Aug 10;91(17). pii: e00377-17. doi: 10.1128/JVI.00377-17. Print 2017 Sep 1.

PMID:
28615208
7.

Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.

Liu Y, Ji H, Zhang Y, Shen X, Gao F, He X, Li GA, Busuttil RW, Kuchroo VK, Kupiec-Weglinski JW.

J Hepatol. 2015 Mar;62(3):563-72. doi: 10.1016/j.jhep.2014.10.034. Epub 2014 Oct 31.

8.

An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.

Khalil SM, Tonkin DR, Snead AT, Parks GD, Johnston RE, White LJ.

J Virol. 2014 Aug;88(16):9182-96. doi: 10.1128/JVI.00327-14. Epub 2014 Jun 4.

9.

Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination.

Hemann EA, Kang SM, Legge KL.

J Immunol. 2013 Sep 1;191(5):2486-94. doi: 10.4049/jimmunol.1300954. Epub 2013 Jul 24.

10.

Tim-3 directly enhances CD8 T cell responses to acute Listeria monocytogenes infection.

Gorman JV, Starbeck-Miller G, Pham NL, Traver GL, Rothman PB, Harty JT, Colgan JD.

J Immunol. 2014 Apr 1;192(7):3133-42. doi: 10.4049/jimmunol.1302290. Epub 2014 Feb 24.

11.

Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.

Wei J, Waithman J, Lata R, Mifsud NA, Cebon J, Kay T, Smyth MJ, Sadler AJ, Chen W.

J Immunol. 2010 Nov 15;185(10):6013-22. doi: 10.4049/jimmunol.1002129. Epub 2010 Oct 18.

12.

Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts.

Wang F, He W, Yuan J, Wu K, Zhou H, Zhang W, Chen ZK.

Transpl Immunol. 2008 Apr;19(1):12-9. doi: 10.1016/j.trim.2008.01.008. Epub 2008 Feb 20.

PMID:
18346632
13.

The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.

Ju Y, Shang X, Liu Z, Zhang J, Li Y, Shen Y, Liu Y, Liu C, Liu B, Xu L, Wang Y, Zhang B, Zou J.

Mol Immunol. 2014 Mar;58(1):85-91. doi: 10.1016/j.molimm.2013.11.001. Epub 2013 Dec 10.

PMID:
24333756
14.

T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner.

Uchida Y, Ke B, Freitas MC, Yagita H, Akiba H, Busuttil RW, Najafian N, Kupiec-Weglinski JW.

Gastroenterology. 2010 Dec;139(6):2195-206. doi: 10.1053/j.gastro.2010.07.003. Epub 2010 Jul 13.

15.

The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.

Brincks EL, Gurung P, Langlois RA, Hemann EA, Legge KL, Griffith TS.

J Immunol. 2011 Nov 1;187(9):4581-8. doi: 10.4049/jimmunol.1002241. Epub 2011 Sep 21.

16.

TIM-3 does not act as a receptor for galectin-9.

Leitner J, Rieger A, Pickl WF, Zlabinger G, Grabmeier-Pfistershammer K, Steinberger P.

PLoS Pathog. 2013 Mar;9(3):e1003253. doi: 10.1371/journal.ppat.1003253. Epub 2013 Mar 21.

17.

17β-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs.

Robinson DP, Hall OJ, Nilles TL, Bream JH, Klein SL.

J Virol. 2014 May;88(9):4711-20. doi: 10.1128/JVI.02081-13. Epub 2014 Feb 12.

18.

Galectin-9 regulates T helper cell function independently of Tim-3.

Su EW, Bi S, Kane LP.

Glycobiology. 2011 Oct;21(10):1258-65. doi: 10.1093/glycob/cwq214. Epub 2010 Dec 27.

19.

Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.

Jin HT, Anderson AC, Tan WG, West EE, Ha SJ, Araki K, Freeman GJ, Kuchroo VK, Ahmed R.

Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14733-8. doi: 10.1073/pnas.1009731107. Epub 2010 Aug 2.

20.

Lymphotoxin-alpha-deficient mice make delayed, but effective, T and B cell responses to influenza.

Lund FE, Partida-Sánchez S, Lee BO, Kusser KL, Hartson L, Hogan RJ, Woodland DL, Randall TD.

J Immunol. 2002 Nov 1;169(9):5236-43.

Supplemental Content

Support Center